Covestus Holdings Limited 11663029 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is of a holding company. Digita Accounts Production Advanced 6.30.9574.0 true false true 11663029 2025-01-01 2025-12-31 11663029 2025-12-31 11663029 core:CurrentFinancialInstruments 2025-12-31 11663029 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 11663029 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 11663029 core:AdditionsToInvestments 2025-12-31 11663029 core:CostValuation 2025-12-31 11663029 bus:SmallEntities 2025-01-01 2025-12-31 11663029 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 11663029 bus:FilletedAccounts 2025-01-01 2025-12-31 11663029 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 11663029 bus:RegisteredOffice 2025-01-01 2025-12-31 11663029 bus:Director2 2025-01-01 2025-12-31 11663029 bus:Director5 2025-01-01 2025-12-31 11663029 bus:Director6 2025-01-01 2025-12-31 11663029 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 11663029 bus:Agent1 2025-01-01 2025-12-31 11663029 core:OtherRelatedParties 2025-01-01 2025-12-31 11663029 countries:EnglandWales 2025-01-01 2025-12-31 11663029 core:CostValuation 2024-12-31 11663029 2024-01-01 2024-12-31 11663029 2024-12-31 11663029 core:CurrentFinancialInstruments 2024-12-31 11663029 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 11663029 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 iso4217:GBP xbrli:pure

Registration number: 11663029

Prepared for the registrar

Covestus Holdings Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2025

 

Covestus Holdings Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

Covestus Holdings Limited

Company Information

Directors

Mr D L Thomas

Mr Q Higham

Mrs L Hitchen

Registered office

Festival House
Jessop Avenue
Cheltenham
GL50 3SH

Accountants

Hazlewoods LLP Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Covestus Holdings Limited

(Registration number: 11663029)
Balance Sheet as at 31 December 2025

Note

2025
£

2024
£

Fixed assets

 

Investments

4

4,702,841

1

Current assets

 

Debtors

5

1,966,619

1,498,739

Cash at bank and in hand

 

488,045

21,386

 

2,454,664

1,520,125

Creditors: Amounts falling due within one year

6

(7,619,899)

(68,111)

Net current (liabilities)/assets

 

(5,165,235)

1,452,014

Total assets less current liabilities

 

(462,394)

1,452,015

Creditors: Amounts falling due after more than one year

6

(50,000)

(1,450,000)

Net (liabilities)/assets

 

(512,394)

2,015

Capital and reserves

 

Called up share capital

250

250

Share premium reserve

149,850

149,850

Retained earnings

(662,494)

(148,085)

Shareholders' (deficit)/funds

 

(512,394)

2,015

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

•

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 25 September 2026 and signed on its behalf by:
 


Mr Q Higham
Director

 

Covestus Holdings Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Festival House
Jessop Avenue
Cheltenham
GL50 3SH
England

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's current forecasts and projections, together with the facilities available to the company, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company is reliant on the continued support from Maven Co-Invest Equinox LP through a loan of £50,000, Covestus Bidco Limited through a loan of £4,876,970 and Covestus Midco Limited through a loan of £1,987,362. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Tax

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Covestus Holdings Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquiisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment. Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Covestus Holdings Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

 

Covestus Holdings Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

 

4

Investments

2025
£

2024
£

Investments in subsidiaries

4,702,841

1

Subsidiaries

£

Cost

At 1 January 2025

1

Additions

4,702,840

At 31 December 2025

4,702,841

Provision

Carrying amount

At 31 December 2025

4,702,841

At 31 December 2024

1

 

5

Debtors

2025
£

2024
£

Receivables from related parties

1,942,849

1,498,639

Prepayments

23,670

-

Other debtors

100

100

1,966,619

1,498,739

 

6

Creditors

2025
£

2024
£

Due within one year

Trade creditors

-

16,911

Amounts due to related parties

6,864,332

50,000

Accruals and deferred income

1,050

1,200

Other creditors

754,517

-

7,619,899

68,111

2025
£

2024
£

Due after one year

Other financial liabilities

50,000

1,450,000

 

Covestus Holdings Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

 

7

Related party transactions

Summary of transactions with other related parties

Covestus Limited
(Subsidiary of Covestus Holdings Limited).
As at the balance sheet date the company was owed £275,279 (2024 - £127,822 was owed to) from Covestus Limited. No interest is charged on the loan and there are no set repayment terms.

Sweat Guard Ltd
(Has a common director with Covestus Holdings Limited)
At the balance sheet date, the company was owed £176,120 (2024 - £25,633) from Sweat Guard Ltd. No interest is charged on the loan and there are no set repayment terms.

Probio Health Limited
(Has a common director with Covestus Holdings Limited)
As at the balance sheet date the company was owed £1,491,450 (2024 - £1,396,450) from Probio Health Limited. No interest is charged on the loan and there are no set repayment terms.

Covestus Bidco
(Parent Company of Covestus Holdings)
As at the balance sheet date the company owed £4,876,970 (2024 - £Nil) to Covestus Bidco Limited. No interest is charged on the loan and there are no set repayment terms.

Covestus Midco
(Parent Company of Covestus Bidco Limited)
As at the balance sheet date the company owed £1,987,362 (2024 - £Nil) to Covestus Midco Limited. No interest is charged on the loan and there are no set repayment terms.

D L Thomas
(A director of Covestus Holdings Limited).
At the balance sheet date, the company owed £Nil (2024 - £50,000) to D L Thomas. No interest is charged on the loan and there are no set repayment terms.